<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR9">
 <label>9.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Akutsu</surname>
    <given-names>Y</given-names>
   </name>
   <name>
    <surname>Kono</surname>
    <given-names>T</given-names>
   </name>
   <name>
    <surname>Uesato</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Hoshino</surname>
    <given-names>I</given-names>
   </name>
   <name>
    <surname>Narushima</surname>
    <given-names>K</given-names>
   </name>
   <name>
    <surname>Hanaoka</surname>
    <given-names>T</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>S-1 monotherapy as second- or third-line chemotherapy for unresectable and recurrent esophageal squamous cell carcinoma</article-title>
  <source>Oncol</source>
  <year>2013</year>
  <volume>84</volume>
  <fpage>305</fpage>
  <lpage>310</lpage>
  <pub-id pub-id-type="doi">10.1159/000348294</pub-id>
 </element-citation>
</ref>
